Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
AEterna Zentaris, Inc. (NASDAQ: AEZS)
Sector: Medical
Current Price :
$2.10
52 Week Low
$1.73
52 Week High
$5.06
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
25M
Market Cap:
$0.04B
Avg Volume:
252706
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 10/5/2012 aezs split by factor of 0.170
1m
3m
6m
1y
2y
Opinion and Analysis
Futures Mixed Amid Claims Data; Fortinet (FTNT) Tumbles
Apr 11, 2013 09:00 AM |
ACAD
,
AEZS
,
APOG
,
BBBY
,
MSFT
,
RAD
Aeterna Zentaris (AEZS) To Discontinue Phase 3 Trial In Multiple Myeloma With Perifosine
Mar 11, 2013 01:11 PM |
AEZS
Stocks End Sharply Lower Amid 'Fiscal Cliff' Fears; HP (HPQ) Falls
Dec 28, 2012 04:18 PM |
AEZS
,
BKS
,
CALL
,
CRZO
,
HPQ
,
PSO
More Articles on AEZS..
Press Releases
Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto
May 15, 2013 07:30 AM |
AEZ
,
AEZS
Aeterna Zentaris Announces Election of Directors at its Annual Meeting of Shareholders
May 08, 2013 04:05 PM |
AEZ
,
AEZS
Aeterna Zentaris Reports First Quarter 2013 Financial and Operating Results
May 07, 2013 04:44 PM |
AEZ
,
AEZS
More Press Releases on AEZS..
SEC Filings
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
AEZS
Compare to S&P
YTD
-25.42 %
-31.61 %
4 Weeks
-9.44 %
-9.34 %
12 Weeks
-31.47 %
-33.77 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
17.14 %
EPS Growth in Last Year:
30.94 %
Sales Growth in Last Quarter:
33.70 %
Sales Growth in Last Quarter:
-24.25 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##